The two forms differ in oxidation state and analytical behavior. An absorbance or fluorescence method may respond differently to each, so the readout must be interpreted accordingly. The sample preparation should preserve the information the assay intends to measure. A label that only says NAD can be insufficient when the method requires a specific form.
Representative product imagery. Verify the physical label and lot documentation on receipt.
Longevity Research
NAD+
In stock·Ships in 1–2 business days
NAD+ supplied in a versatile 500 mg research size. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size2 options
Select pack sizeSave 18% on kits
1 × 500 mg$63.99
In stockSelected size 500 mgSC-NAD-500
Transparent volume pricing10-vial peptide kits save 18%.
Secure checkout US & EU dispatch
Research use only acknowledgment required at checkout
Report not published
Compound context
What researchers study
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a cofactor used in biochemical research. It is not a peptide. This listing supplies laboratory material for methods that specify the oxidized analyte. The NAD plus injection phrase often concerns clinical infusions, which are a different product and evidence category from this research reference.
Enzymes can use NAD+ in redox reactions or consume it in other biochemical processes. NADH is a different form with different measurement properties. A result that combines them without explanation can obscure the actual question. An infusion pilot measured plasma and urine metabolites, but that design does not establish a general anti aging benefit.
Extraction and sample handling can change the observed balance between oxidized and reduced forms. A method should state whether it measures a pool, a ratio or a reaction rate. Calibration and recovery checks need to match that definition. A high numerical result is not inherently better because its meaning depends on the biological and analytical context.
Scope limitConfirm the oxidized form and the relevant analytical record before assay use. Serenity research material is not an infusion product or a personal dosage plan. Published clinical formulations do not establish this vial's suitability for administration.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
Reaction rate depends on the enzyme system and the available substrates under the tested conditions. Increasing cofactor concentration does not necessarily increase the rate indefinitely. A controlled comparison can investigate that relationship. The resulting kinetics describe the assay and cannot establish a personal energy or longevity outcome.
A study of circulating metabolites can show how measured compounds change during a specific intervention. It cannot automatically establish improved health or delivery into every tissue. NAD+ injections discussed in clinical literature require their own formulation and safety context. Research procurement remains a separate activity with a different purpose and scope.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateNAD+ · Report not publishedSee original reportView report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
